Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Ruigang Cai"'
Autor:
Nilupai Abudureheiyimu, Yun Wu, Qing Li, Pin Zhang, Fei Ma, Peng Yuan, Yang Luo, Ying Fan, Shanshan Chen, Ruigang Cai, Qiao Li, Yiqun Han, Hangcheng Xu, Yan Wang, Jiayu Wang, Binghe Xu
Publikováno v:
Journal of the National Cancer Center, Vol 3, Iss 2, Pp 115-120 (2023)
Background: This study was conducted to evaluate the efficacy and safety of docetaxel/S-1 (TS) compared with docetaxel/capecitabine (TX) as a first-line treatment for advanced breast cancer. Methods: Patients with advanced metastatic breast cancer we
Externí odkaz:
https://doaj.org/article/bf189502917f411b965b9ef9c0262bd4
Autor:
Xiuwen Guan, Fei Ma, Qiao Li, Shanshan Chen, Bo Lan, Ying Fan, Jiayu Wang, Yang Luo, Ruigang Cai, Pin Zhang, Qing Li, Binghe Xu
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-10 (2023)
Abstract Background Pyrotinib, a novel irreversible tyrosine kinase inhibitor (TKI), has demonstrated promising antitumor activity to improve the overall response rate and progression-free survival (PFS) in patients with HER2-positive metastatic brea
Externí odkaz:
https://doaj.org/article/96394d04c5794293929250685072392e
Autor:
Hongnan Mo, Fei Ma, Qing Li, Pin Zhang, Peng Yuan, Jiayu Wang, Yang Luo, Ruigang Cai, Qiao Li, Binghe Xu, Xiuyuan Hao
Publikováno v:
Chinese Medical Journal, Vol 135, Iss 14, Pp 1734-1741 (2022)
Abstract. Background:. This study aimed to reveal the treatment patterns and clinical outcomes of diverse palbociclib-based regimens in Han patients with estrogen receptor-positive (ER+) metastatic breast cancer in routine clinical practice. Methods:
Externí odkaz:
https://doaj.org/article/ad10eba35e5c4736b4b35e6e95d2e2d9
Autor:
Yiqun Li, Hongnan Mo, Xiuwen Guan, Shaoyan Lin, Zijing Wang, Yimeng Chen, Shanshan Chen, Qiao Li, Ruigang Cai, Jiayu Wang, Yang Luo, Ying Fan, Peng Yuan, Pin Zhang, Qing Li, Fei Ma, Binghe Xu
Publikováno v:
Breast, Vol 61, Iss , Pp 129-135 (2022)
Background: To observe whether guideline non-adherence in initial palliative treatment choices for premenopausal hormone receptor-positive (HR+), HER2-negative metastatic breast cancer (MBC) patients result in worse clinical outcomes in the Chinese p
Externí odkaz:
https://doaj.org/article/3774f6ea8b7044b082700e355a54575d
Autor:
Xiaoyan Qian, Meng Xiu, Qing Li, Jiayu Wang, Ying Fan, Yang Luo, Ruigang Cai, Qiao Li, Shanshan Chen, Peng Yuan, Fei Ma, Binghe Xu, Pin Zhang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundAlthough achieving pathological complete response (pCR) and near-pathological complete response (near-pCR) after neoadjuvant chemotherapy (NAC) in breast cancer predicts a better outcome, some patients still experience recurrence. The aim o
Externí odkaz:
https://doaj.org/article/a276ab95dd2e4c49a9f6f8fe3d0e9e96
Autor:
Hangcheng Xu, Yiqun Han, Yun Wu, Yan Wang, Qing Li, Pin Zhang, Peng Yuan, Yang Luo, Ying Fan, Shanshan Chen, Ruigang Cai, Qiao Li, Fei Ma, Binghe Xu, Jiayu Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundHuman epidermal growth factor 2 (HER2)-low breast cancer, which is defined as HER2 1+ or 2+ in immunohistochemistry without gene amplification, accounts for a considerable part of all breast cancers. However, it remains controversial whethe
Externí odkaz:
https://doaj.org/article/d939eddcb2384157b352ee2f6713de35
Autor:
Yiqun Li, Qiao Li, Hongnan Mo, Xiuwen Guan, Shaoyan Lin, Zijing Wang, Yimeng Chen, Ye Zhang, Dainan Zhang, Shanshan Chen, Ruigang Cai, Jiayu Wang, Yang Luo, Ying Fan, Peng Yuan, Pin Zhang, Qing Li, Fei Ma, Binghe Xu
Publikováno v:
Breast, Vol 55, Iss , Pp 30-36 (2021)
Purpose: To characterize the incidence, risk factors and survival of patients with brain metastases at initial diagnosis of metastatic breast cancer (MBC) in China. Methods: The China National Cancer Center database was used to identify 2087 MBC pati
Externí odkaz:
https://doaj.org/article/ed344ddec995463fb55d6077523d3a9d
Autor:
Meng Xiu, Pin Zhang, Qing Li, Peng Yuan, Jiayu Wang, Yang Luo, Fei Ma, Ruigang Cai, Ying Fan, Qiao Li, Binghe Xu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Data regarding chemotherapy options and benefits in older women with early triple-negative breast cancer (TNBC) are limited. Our study aimed to assess the effects of adjuvant chemotherapy on recurrence-free survival (RFS), breast cancer-specific surv
Externí odkaz:
https://doaj.org/article/5dc9d2fa0a084fdcbde1d342bdbe95ae
Autor:
Shaoyan Lin, Hongnan Mo, Yiqun Li, Xiuwen Guan, Yimeng Chen, Zijing Wang, Peng Yuan, Jiayu Wang, Yang Luo, Ying Fan, Ruigang Cai, Qiao Li, Shanshan Chen, Pin Zhang, Qing Li, Fei Ma, Binghe Xu
Publikováno v:
Breast, Vol 53, Iss , Pp 172-180 (2020)
Background: There is a lack of prognostic models predicting the overall survival (OS) of advanced breast cancer (ABC) patients in China. Methods: Data from the China National Cancer Center database that recorded 4039 patients diagnosed with breast ca
Externí odkaz:
https://doaj.org/article/02a7eb8753874b56b61477328583b276
Autor:
Yiqun Li, Nilupai Abudureheiyimu, Hongnan Mo, Xiuwen Guan, Shaoyan Lin, Zijing Wang, Yimeng Chen, Shanshan Chen, Qiao Li, Ruigang Cai, Jiayu Wang, Yang Luo, Ying Fan, Peng Yuan, Pin Zhang, Qing Li, Fei Ma, Binghe Xu
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
BackgroundTo characterize the clinical and pathological features and survival of patients with human epidermal growth factor receptor 2 (HER2)-low breast cancer in China.MethodsThe China National Cancer Center database was used to identify 1,433 meta
Externí odkaz:
https://doaj.org/article/19ed20b5eea34fae87db2f216a0e0e79